Menu
Recruiting NCT06311162

Early Life Intervention in Pediatrics Supported by E-health - SMOKE

No phase Interventional Smoking Reduction Asthma in Children Wheezing Non-Communicable Disease

For patients and families

In plain language

Fill the application

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Life-Style app, Sham Comparator.
Who it may be relevant to
Registry conditions: Smoking Reduction, Asthma in Children, Wheezing, Non-Communicable Disease. Basic parameters: up to 5 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Switzerland
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Early Life Intervention in Pediatrics Supported by E-health (ELIPSE II): Coaching Parents to Lower Second-hand Smoke Exposure in Children A Single-blind Randomized Controlled Parallel-group Clinical Trial

Overview

Unrestricted parental smoking habits are lifestyle risk behaviors associated with chronic, systemic inflammation, which promotes the pathogenesis of non-communicable diseases (NCDs). Exposure to secondhand tobacco smoke in early life contributes to the development of specific NCDs in children, i.e. asthma. Early preventive measures to improve lifestyle behavior in parents are therefore of utmost importance. The aim of ELIPSE-II is to assess whether an eHealth application intervention for parents is feasible and efficacious in lowering levels of urinary cotinine as a measure of second-hand smoke exposure in their children .

Detailed description

ELIPSE-II represents a single-blind randomized controlled parallel-group clinical trial. In total, 160 children, \<6 years of age with exposure to second-hand smoke at home will be included. Children will be recruited at the children's university hospital and in private practices in Bern, and randomly (1:1) assigned to a control and intervention group.

All participants receive treatment-as-usual (TAU), parents of participants in the intervention group additionally receive a smartphone application (lifestyle app) for 20 weeks. The app aims to promote healthy behavior through cognitive-behavioral impact factors (i.e., psychoeducation, goal setting), that are applied by a psychologist via structured feedback. Single-blinded assessments will be conducted at baseline, following the intervention period of 20 weeks, and at 6-month follow-up after the end of the intervention. The primary endpoint is reduction of exposure to second-hand smoke exposure assessed by urinary levels of cotinine. Secondary endpoints in ELIPSE-II include changes in parental smoking habits and effects of the intervention on infants' respiratory health. A further endpoint is acceptance and usability of the app.

Interventions

  • Behavioral Life-Style app
    The modules of the Life-Style app are introduced and unlocked sequentially during the first weeks of the intervention phase. Afterwards the modules are fully available. Duration and frequency of app-use is not limited. The parents are accompanied by a coach through the app, who gives regular structured feedback and individual inputs. The coach has access to all data collected in the app.
  • Other Sham Comparator
    The parents get a flyer with information on second-hand smoke exposure and references to smoking cessation programs, and do not have an active app during the main intervention period.

Primary outcome measures

  • Change from baseline in urinary levels of cotinine in children [Time frame: At 22 weeks after baseline (Post intervention)]
  • Change from baseline in urinary levels of cotinine in children [Time frame: At 48 weeks after baseline (Follow-Up)]
Secondary outcome measures (1)
  • Change from baseline in protective measures taken by parents to protect children from second-hand smoke exposure [Time frame: During intervention (week 2-22), post intervention (week 22-23) and follow-up (week 48-49)]

Eligibility criteria

Inclusion criteria

  • Age: younger than 6 years
  • Exposed to second-hand smoke at home (at least one parent smoking)
  • German speaking parent
  • All sex and ethnic backgrounds
  • Signed informed consent form from parent
  • Children live/grow-up in the same household as the parental participant
  • Referred by a health care professional (e.g. physician, midwife, nurse, other professions)

Exclusion criteria

  • Participation in another study/trial targeting similar outcomes
  • Participation in an active smoking cessation programme

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Double blind
Primary purpose
Prevention

Study locations

Switzerland · 1 center
  • Department of Paediatrics, Inselspital, Bern University Hospital — Bern

Publications

  • Koch A, Wyssen A, Haupt C, Hammelbeck J, van Dorland HA, Fluck CE, Latzin P, Saner C, Jakob J, Kaess M, Kopp MV. Early Life Intervention in Paediatrics Supported by E-Health (ELIPSE)-a coaching app for parents to reduce obesity and second-hand smoke exposure in children: study protocols for two parallel-group randomised controlled trials. Trials. 2025 Nov 18;26(1):520. doi: 10.1186/s13063-025-0925 PMID 41254719

Identifiers

NCT: NCT06311162 · 2023-01615

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗